| scholarly article | Q13442814 |
| P2093 | author name string | Shawn D St Peter | |
| Peter J Friend | |||
| Charles J Imber | |||
| Inigo Lopez | |||
| Lynden Guiver | |||
| P2860 | cites work | Primary nonfunction of hepatic allografts with preexisting fatty infiltration | Q34256918 |
| Use of livers with microvesicular fat safely expands the donor pool | Q39227544 | ||
| Body mass index as a predictor of hepatic steatosis in living liver donors | Q40708465 | ||
| Irregular fatty infiltration of the liver: diagnostic dilemmas | Q41480802 | ||
| Hepatic steatosis in liver transplant donors: common feature of donor population? | Q43736014 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 545-549 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | Liver Transplantation | Q15730498 |
| P1476 | title | Current practice regarding the use of fatty livers: a trans-Atlantic survey | |
| P478 | volume | 8 |
| Q46769638 | Assessment of hepatic steatosis by transplant surgeon and expert pathologist: a prospective, double-blind evaluation of 201 donor livers |
| Q37961687 | Assessment of liver transplant donor biopsies for steatosis using frozen section: accuracy and possible impact on transplantation |
| Q36495377 | Auxiliary partial liver transplantation for acute liver failure using "high risk" grafts: Case report |
| Q36503848 | Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death. |
| Q80381331 | Does donor's fatty liver change impact on early mortality and outcome of liver transplantation |
| Q38445234 | Donor Hepatic Steatosis and Outcome After Liver Transplantation: a Systematic Review. |
| Q40550088 | Excellent outcomes of liver transplantation using severely steatotic grafts from brain-dead donors. |
| Q35010235 | Hepatic steatosis is not always a contraindication for cadaveric liver transplantation |
| Q95313409 | Liver Steatosis in Brain-Dead Donors: Progression Pattern and Affecting Factors |
| Q35745702 | Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation |
| Q43663227 | Oil Red O-assessed macrosteatosis in liver transplant donor biopsies predicts ischemia-reperfusion injury and clinical outcome |
| Q53692143 | Organ Procurement Organization Survey of Practices and Beliefs Regarding Prerecovery Percutaneous Liver Biopsy in Donation After Neurologic Determination of Death. |
| Q52991512 | Predictive Value of Unenhanced Computerized Tomography for Detecting Hepatosteatosis in Living Liver Donors. |
| Q91850773 | Reliability and Accuracy of Clinical Assessment and Digital Image Analysis for Steatosis Evaluation in Discarded Human Livers |
| Q56460450 | Retraction: “Safety limitations of fatty liver transplantation can be extended to 40%: Experience of a single centre in China”, by Yu Z., Yu S., Zhang L., Feng X., Zhang M., et al |
| Q51168590 | Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithm. |
| Q43173972 | Short-term therapy with peroxisome proliferation-activator receptor-alpha agonist Wy-14,643 protects murine fatty liver against ischemia-reperfusion injury |
| Q36172774 | Survival after liver transplantation in the United Kingdom and Ireland compared with the United States |
| Q80526264 | [Orthotopic liver transplantation. Techniques and results] |
Search more.